Goyal Vikas

CIK 00017210173 companiesCONSHOHOCKEN, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001721017

Recent Transactions

27 trades

Disposition to Issuer
Pandion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2021-04-01−28,227→ 0 total
Disposition to Issuer
Pandion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2021-04-01−73,789→ 0 total
Disposition from Tender
Pandion Therapeutics, Inc.
Common Stock
2021-04-01$60.00/sh−87,764→ 0 total
Purchase
Morphic Holding, Inc.
Common Stock
2021-03-05$70.00/sh+1,000→ 1,000 total
Award
Pandion Therapeutics, Inc.
Stock Option (right to buy)
2021-02-08+73,789→ 73,789 total
Conversion
Pandion Therapeutics, Inc.
Common Stock
2020-07-21+7,044→ 86,314 total
Purchase
Pandion Therapeutics, Inc.
Common Stock
2020-07-21$18.00/sh+1,450→ 87,764 total
Conversion
Pandion Therapeutics, Inc.
Series B Preferred Stock
2020-07-21−35,922→ 0 total
Award
Pandion Therapeutics, Inc.
Stock Option (right to buy)
2020-07-17+3,806→ 3,806 total
Award
Pandion Therapeutics, Inc.
Stock Option (right to buy)
2020-07-17+10,486→ 10,486 total
Award
Pandion Therapeutics, Inc.
Stock Option (right to buy)
2020-07-17+13,935→ 13,935 total
Award
Morphic Holding, Inc.
Director Stock Option (right to buy)
2020-06-18+12,000→ 12,000 total
Award
Morphic Holding, Inc.
Stock Option (right to buy Common Stock)
2019-08-01+24,000→ 24,000 total
Conversion
Morphic Holding, Inc.
Series B Preferred Stock
2019-07-01−830,489→ 0 total
Conversion
Morphic Holding, Inc.
Common Stock
2019-07-01+1,469,950→ 1,469,950 total
Conversion
Morphic Holding, Inc.
Common Stock
2019-07-01+830,489→ 2,300,439 total
Conversion
Morphic Holding, Inc.
Series A Preferred Stock
2019-07-01−1,469,950→ 0 total
Purchase
Morphic Holding, Inc.
Common Stock
2019-07-01$15.00/sh+333,333→ 2,633,772 total
Conversion
Spero Therapeutics, Inc.$SPRO
Common Stock
2017-11-06+244,147→ 244,147 total
Conversion
Spero Therapeutics, Inc.$SPRO
Common Stock
2017-11-06+246,272→ 490,419 total
Conversion
Spero Therapeutics, Inc.$SPRO
Common Stock
2017-11-06+328,992→ 819,411 total
Conversion
Spero Therapeutics, Inc.$SPRO
Common Stock
2017-11-06+606,024→ 1,425,435 total
Purchase
Spero Therapeutics, Inc.$SPRO
Common Stock
2017-11-06$14.00/sh+428,571→ 1,854,006 total
Conversion
Spero Therapeutics, Inc.$SPRO
Junior preferred stock
2017-11-06−1,483,784→ 0 total
Conversion
Spero Therapeutics, Inc.$SPRO
Series A preferred stock
2017-11-06−982,906→ 0 total
Conversion
Spero Therapeutics, Inc.$SPRO
Series B preferred stock
2017-11-06−1,250,000→ 0 total
Conversion
Spero Therapeutics, Inc.$SPRO
Series C preferred stock
2017-11-06−3,683,045→ 0 total

Companies

Recent Filings

Address

C/O S.R. ONE, LIMITED 161 WASHINGTON STREET, SUITE 500

CONSHOHOCKEN, PA, 19428

View on SEC.gov